Annual Revenue
$486.82 M
+$170.43 M+53.87%
31 December 2023
Summary:
ANI Pharmaceuticals annual revenue is currently $486.82 million, with the most recent change of +$170.43 million (+53.87%) on 31 December 2023. During the last 3 years, it has risen by +$278.34 million (+133.51%). ANIP annual revenue is now at all-time high.ANIP Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$148.33 M
+$10.29 M+7.46%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly revenue is currently $148.33 million, with the most recent change of +$10.29 million (+7.46%) on 30 September 2024. Over the past year, it has increased by +$16.50 million (+12.52%). ANIP quarterly revenue is now at all-time high.ANIP Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$555.46 M
+$16.50 M+3.06%
30 September 2024
Summary:
ANI Pharmaceuticals TTM revenue is currently $555.46 million, with the most recent change of +$16.50 million (+3.06%) on 30 September 2024. Over the past year, it has increased by +$106.06 million (+23.60%). ANIP TTM revenue is now at all-time high.ANIP TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.9% | +12.5% | +23.6% |
| 3 y3 years | +133.5% | +184.9% | +161.4% |
| 5 y5 years | +141.5% | +188.9% | +157.5% |
ANIP Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +133.5% | at high | +184.9% | at high | +161.4% |
| 5 y | 5 years | at high | +141.5% | at high | +209.2% | at high | +181.2% |
| alltime | all time | at high | at high | >+9999.0% | at high | >+9999.0% |
ANI Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $148.33 M(+7.5%) | $555.46 M(+3.1%) |
| June 2024 | - | $138.04 M(+0.4%) | $538.95 M(+4.2%) |
| Mar 2024 | - | $137.43 M(+4.4%) | $517.46 M(+6.3%) |
| Dec 2023 | $486.82 M(+53.9%) | $131.65 M(-0.1%) | $486.82 M(+8.3%) |
| Sept 2023 | - | $131.83 M(+13.1%) | $449.39 M(+12.0%) |
| June 2023 | - | $116.55 M(+9.1%) | $401.39 M(+11.9%) |
| Mar 2023 | - | $106.79 M(+13.3%) | $358.69 M(+13.4%) |
| Dec 2022 | $316.38 M(+46.4%) | $94.23 M(+12.4%) | $316.38 M(+11.8%) |
| Sept 2022 | - | $83.82 M(+13.5%) | $283.08 M(+12.6%) |
| June 2022 | - | $73.86 M(+14.5%) | $251.32 M(+11.2%) |
| Mar 2022 | - | $64.48 M(+5.8%) | $226.09 M(+4.6%) |
| Dec 2021 | $216.14 M(+3.7%) | $60.93 M(+17.0%) | $216.14 M(+1.7%) |
| Sept 2021 | - | $52.06 M(+7.1%) | $212.46 M(-0.4%) |
| June 2021 | - | $48.63 M(-10.8%) | $213.38 M(+0.1%) |
| Mar 2021 | - | $54.52 M(-4.8%) | $213.22 M(+2.3%) |
| Dec 2020 | $208.47 M(+0.9%) | $57.25 M(+8.1%) | $208.47 M(+4.7%) |
| Sept 2020 | - | $52.98 M(+9.3%) | $199.19 M(+0.8%) |
| June 2020 | - | $48.47 M(-2.6%) | $197.55 M(-2.9%) |
| Mar 2020 | - | $49.77 M(+3.8%) | $203.43 M(-1.5%) |
| Dec 2019 | $206.55 M(+2.5%) | $47.97 M(-6.6%) | $206.55 M(-4.2%) |
| Sept 2019 | - | $51.34 M(-5.6%) | $215.70 M(+0.3%) |
| June 2019 | - | $54.36 M(+2.8%) | $215.07 M(+3.4%) |
| Mar 2019 | - | $52.89 M(-7.4%) | $207.98 M(+3.2%) |
| Dec 2018 | $201.58 M(+14.0%) | $57.12 M(+12.7%) | $201.58 M(+5.1%) |
| Sept 2018 | - | $50.70 M(+7.3%) | $191.74 M(+1.3%) |
| June 2018 | - | $47.27 M(+1.7%) | $189.20 M(+1.3%) |
| Mar 2018 | - | $46.48 M(-1.7%) | $186.70 M(+5.6%) |
| Dec 2017 | $176.84 M(+37.5%) | $47.29 M(-1.8%) | $176.84 M(+5.4%) |
| Sept 2017 | - | $48.16 M(+7.6%) | $167.76 M(+6.1%) |
| June 2017 | - | $44.76 M(+22.2%) | $158.12 M(+9.3%) |
| Mar 2017 | - | $36.63 M(-4.1%) | $144.69 M(+12.5%) |
| Dec 2016 | $128.62 M(+68.5%) | $38.20 M(-0.8%) | $128.62 M(+18.6%) |
| Sept 2016 | - | $38.52 M(+22.9%) | $108.45 M(+20.6%) |
| June 2016 | - | $31.34 M(+52.5%) | $89.90 M(+15.1%) |
| Mar 2016 | - | $20.55 M(+14.0%) | $78.08 M(+2.3%) |
| Dec 2015 | $76.32 M(+36.4%) | $18.04 M(-9.7%) | $76.32 M(-3.8%) |
| Sept 2015 | - | $19.97 M(+2.3%) | $79.32 M(+3.4%) |
| June 2015 | - | $19.52 M(+3.8%) | $76.74 M(+20.1%) |
| Mar 2015 | - | $18.80 M(-10.6%) | $63.87 M(+14.1%) |
| Dec 2014 | $55.97 M(+86.1%) | $21.04 M(+21.0%) | $55.97 M(+23.1%) |
| Sept 2014 | - | $17.39 M(+161.6%) | $45.47 M(+26.6%) |
| June 2014 | - | $6.65 M(-39.0%) | $35.91 M(+1.4%) |
| Mar 2014 | - | $10.90 M(+3.5%) | $35.42 M(+43.6%) |
| Dec 2013 | $30.08 M(+1207.5%) | $10.53 M(+34.4%) | $24.66 M(+53.2%) |
| Sept 2013 | - | $7.84 M(+27.4%) | $16.10 M(+92.2%) |
| June 2013 | - | $6.15 M(+4142.8%) | $8.38 M(+259.2%) |
| Mar 2013 | - | $145.00 K(-92.6%) | $2.33 M(+1.3%) |
| Dec 2012 | $2.30 M | $1.97 M(+1682.2%) | $2.30 M(+414.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $110.40 K(+1.5%) | $447.60 K(-13.9%) |
| June 2012 | - | $108.80 K(-4.6%) | $520.00 K(+5.6%) |
| Mar 2012 | - | $114.00 K(-0.3%) | $492.20 K(+13.1%) |
| Dec 2011 | $435.20 K(-82.4%) | $114.40 K(-37.4%) | $435.20 K(-6.2%) |
| Sept 2011 | - | $182.80 K(+125.7%) | $463.80 K(+39.6%) |
| June 2011 | - | $81.00 K(+42.1%) | $332.30 K(+32.2%) |
| Mar 2011 | - | $57.00 K(-60.1%) | $251.30 K(-89.8%) |
| Dec 2010 | $2.47 M(+96.7%) | $143.00 K(+178.8%) | $2.47 M(-27.1%) |
| Sept 2010 | - | $51.30 K(-97.7%) | $3.40 M(-2.1%) |
| Mar 2010 | - | $2.28 M(+114.3%) | $3.47 M(+175.8%) |
| Dec 2009 | $1.26 M(-66.7%) | $1.06 M(>+9900.0%) | $1.26 M(-66.9%) |
| Sept 2009 | - | $10.50 K(-90.9%) | $3.80 M(-1.9%) |
| June 2009 | - | $115.20 K(+68.4%) | $3.88 M(+2.4%) |
| Mar 2009 | - | $68.40 K(-98.1%) | $3.79 M(+0.6%) |
| Dec 2008 | $3.78 M(+666.7%) | $3.61 M(+4291.5%) | $3.76 M(+679.4%) |
| Sept 2008 | - | $82.20 K(+217.4%) | $482.90 K(+8.6%) |
| June 2008 | - | $25.90 K(-43.2%) | $444.50 K(-8.9%) |
| Mar 2008 | - | $45.60 K(-86.1%) | $488.00 K(-1.0%) |
| Dec 2007 | $493.10 K(-96.6%) | $329.20 K(+651.6%) | $493.00 K(-96.5%) |
| Sept 2007 | - | $43.80 K(-36.9%) | $14.20 M(-0.7%) |
| June 2007 | - | $69.40 K(+37.2%) | $14.30 M(-0.7%) |
| Mar 2007 | - | $50.60 K(-99.6%) | $14.40 M(-0.2%) |
| Dec 2006 | $14.44 M(+5487.7%) | $14.04 M(>+9900.0%) | $14.44 M(+2803.4%) |
| Sept 2006 | - | $140.30 K(-20.0%) | $497.30 K(+12.0%) |
| June 2006 | - | $175.30 K(+107.0%) | $444.10 K(+41.3%) |
| Mar 2006 | - | $84.70 K(-12.7%) | $314.40 K(+21.7%) |
| Dec 2005 | $258.40 K(+231.7%) | $97.00 K(+11.4%) | $258.40 K(+19.5%) |
| Sept 2005 | - | $87.10 K(+91.0%) | $216.20 K(+54.5%) |
| June 2005 | - | $45.60 K(+58.9%) | $139.90 K(+40.9%) |
| Mar 2005 | - | $28.70 K(-47.6%) | $99.30 K(+27.5%) |
| Dec 2004 | $77.90 K(+18.9%) | $54.80 K(+407.4%) | $77.90 K(-339.0%) |
| Sept 2004 | - | $10.80 K(+116.0%) | -$32.60 K(+81.1%) |
| June 2004 | - | $5000.00(-31.5%) | -$18.00 K(-21.7%) |
| Mar 2004 | - | $7300.00(-113.1%) | -$23.00 K(-142.6%) |
| Dec 2003 | $65.50 K(-97.7%) | -$55.70 K(-319.3%) | $54.00 K(-97.2%) |
| Sept 2003 | - | $25.40 K(-69.9%) | $1.95 M(-32.4%) |
| Mar 2003 | - | $84.30 K(-95.4%) | $2.89 M(+3.0%) |
| Dec 2002 | $2.83 M(+62.2%) | $1.84 M(+91.3%) | $2.80 M(+191.3%) |
| Sept 2002 | - | $962.60 K(-44.9%) | $962.60 K(-52.5%) |
| Dec 2001 | $1.75 M(+667.4%) | - | - |
| Sept 2001 | - | $1.75 M(+3339.8%) | $2.03 M(+627.4%) |
| June 2001 | - | $50.80 K(>+9900.0%) | $278.50 K(-3.7%) |
| Mar 2001 | - | $0.00(-100.0%) | $289.20 K(0.0%) |
| Dec 2000 | $227.70 K(>+9900.0%) | $227.70 K(>+9900.0%) | $289.20 K(+370.2%) |
| Sept 2000 | - | $0.00(-100.0%) | $61.50 K(0.0%) |
| June 2000 | - | $61.50 K(>+9900.0%) | $61.50 K(>+9900.0%) |
| Mar 2000 | - | $0.00 | $0.00 |
| Dec 1999 | $0.00(-100.0%) | - | - |
| Dec 1998 | $123.10 K | - | - |
FAQ
- What is ANI Pharmaceuticals annual revenue?
- What is the all time high annual revenue for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual revenue year-on-year change?
- What is ANI Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly revenue year-on-year change?
- What is ANI Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM revenue year-on-year change?
What is ANI Pharmaceuticals annual revenue?
The current annual revenue of ANIP is $486.82 M
What is the all time high annual revenue for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual revenue is $486.82 M
What is ANI Pharmaceuticals annual revenue year-on-year change?
Over the past year, ANIP annual revenue has changed by +$170.43 M (+53.87%)
What is ANI Pharmaceuticals quarterly revenue?
The current quarterly revenue of ANIP is $148.33 M
What is the all time high quarterly revenue for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly revenue is $148.33 M
What is ANI Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, ANIP quarterly revenue has changed by +$16.50 M (+12.52%)
What is ANI Pharmaceuticals TTM revenue?
The current TTM revenue of ANIP is $555.46 M
What is the all time high TTM revenue for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM revenue is $555.46 M
What is ANI Pharmaceuticals TTM revenue year-on-year change?
Over the past year, ANIP TTM revenue has changed by +$106.06 M (+23.60%)